Thrive Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Isomorphic Labs
11 May 2026
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Isomorphic Labs
31 Mar 2025
Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.
Thrive Capital
- 1(12 months)
- thrivecap.com
- Update Information
More venture news
- 28 May 2026
Orbital IndustriesOrbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model
Series BAI - 20 May 2026
RemotePassRemotePass unlocks £13m Series B led by EBRD VC for cross-border payroll and workforce management platform
Series BEnterprise - 14 May 2026
IceotopeIceotope raises £19m Series B led by Two Seas Capital and Barclays Climate Ventures for liquid cooling systems for AI data infrastructure
Series BAI
